SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001599298-24-000098
Filing Date
2024-06-13
Accepted
2024-06-13 14:03:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A summit-defa14axmahatmeresi.htm DEFA14A 15993
  Complete submission text file 0001599298-24-000098.txt   17227
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36866 | Film No.: 241040771
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)